Results 81 to 90 of about 1,434 (169)

Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel

open access: yesТерапевтический архив
A meeting of the Expert Council on September 9, 2023 considered the last challenges in the treatment of osteoarthritis (OA) including OA in comorbid patients.
Vadim I. Mazurov   +10 more
doaj   +1 more source

Nanotechnologies for Boswellic Acids

open access: yesAmerican Journal of Drug Discovery and Development, 2013
Meenu Mehta   +3 more
openaire   +1 more source

Review on Pharmacological Activities of Gum olibanum

open access: yesJournal of Medicinal Plants, 2009
Frankincense, also known as olibanum, is a gum resin collected from trees of the genus Boswellia. The gum resin is produced by trees of various Boswellia species. These plants are middle size trees from Burseraceae family.
B Tavakkolifar   +2 more
doaj  

QbD-guided phospholipid-tagged nanonized boswellic acid naturosomal delivery for effective rheumatoid arthritis treatment

open access: yesInternational Journal of Pharmaceutics: X
Studies have reported the potential role of Boswellic acids (BAs), bioactive pentacyclic triterpenes from Boswellia serrata (BS), in treating rheumatoid arthritis (RA).
Poonam Usapkar   +11 more
doaj   +1 more source

Photochemically synthesized gold nanoparticles conjugated with Boswellic acid inhibit alpha synuclein aggregation and delay fibrillation kinetics

open access: yesScientific Reports
Neurodegenerative disorders are characterised by the gradual degeneration and death of neurons in distinct brain regions. In Parkinson’s disease (PD), a key pathological hallmark is the aggregation of misfolded α-synuclein (α-Syn) into neurotoxic fibrils.
Masoumeh Gharb   +4 more
doaj   +1 more source

Herbal medicine meets machine learning: a systematic review of AI-powered innovation in chronic inflammation management

open access: yesDiscover Applied Sciences
Chronic inflammatory diseases (CIDs) impose a significant global health burden, affecting over 350 million people and incurring annual healthcare costs exceeding $500 billion.
Aidin Shahrezaei   +4 more
doaj   +1 more source

An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases. [PDF]

open access: yesInt J Mol Sci, 2019
Roy NK   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy